FDA Clears 786,000 Jynneos Vaccine Doses Produced In Denmark

FDA has approved 786,000 doses of Bavarian Nordic’s Jynneos monkeypox vaccine, which were produced at the company’s fill-and-finish facility in Denmark, for use in the United States, HHS and FDA announced Wednesday (July 27). The additional doses will be made available to states and jurisdictions as soon as possible. HHS will announce allocations Thursday (July 28), HHS Secretary Xavier Becerra said. The 786,000 doses are in addition to the 7 million Jynneos doses the government has already purchased, some of...